Results 271 to 280 of about 884,783 (299)
Some of the next articles are maybe not open access.

AIDS-Antiviral Natural Products Research at The U.S. National Cancer Institute

1992
The Laboratory of Drug Discovery Research and Development (LDDRD) is a new intramural NCI laboratory within the Division of Cancer Treatment’s Developmental Therapeutics Program. The primary research focus in LDDRD includes the development and refinement of the NCI anti-HIV and antitumor screening models, the bioassay-guided isolation of new active ...
Kirk R. Gustafson   +5 more
openaire   +1 more source

Cancer Informatics Collaboration and Computation: Two Initiatives of the U.S. National Cancer Institute 

2015
One of the objectives of the U.S. National Cancer Institute’s Center for Biomedical Informatics and Information Technology is to focus on innovative programs and technologies to support the use of informatics in cancer research and encourage open science.
Ishwar Chandramouli   +4 more
openaire   +1 more source

Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events

Journal of Pain and Symptom Management, 2020
To improve precision and accuracy in the capture of symptomatic adverse events (AEs) by self-report, the U.S. National Cancer Institute has developed a library of 124 patient-reported outcome (PRO) items reflecting 78 symptomatic AEs drawn from the Common Terminology Criteria for Adverse Events (CTCAE).
Junghee Yoon   +10 more
openaire   +2 more sources

NCIP Hub and Cancer Genomics Cloud Pilots – Two U.S. National Cancer Institute Initiatives

2015
One of the objectives of the U.S. National Cancer Institute’s Center for Biomedical Informatics and Information Technology is to focus on innovative programs and technologies to support the use of informatics in cancer research and encourage open science.
Ishwar Chandramouli   +4 more
openaire   +1 more source

Effect of 9–11 on U.S. national cancer clinical trials accrual and lack of effect of National Cancer Institute budget increases

Journal of Clinical Oncology, 2007
6551 Background: During the past decade, a variety of initiatives have been implemented to improve the accrual of cancer patients on clinical trials. In the U.S., these have included comprehensive reviews and recommendations by the two most recent National Cancer Institute (NCI) administrations, reorganization of the clinical trials infrastructure at
openaire   +1 more source

Information Oncologic Tools Produced by the U.S. National Cancer Institute: How Much are They Known and Used? Results of an Enquiry in Italy

Tumori Journal, 1995
A survey was conducted among specialized users in order to establish the level of knowledge and diffusion of four informative tools: Cancerlit, PDQ, Clinprot, Cancergram. A questionnaire was distributed to 975 graduate researchers working in four national cancer research institutes in the north (2), center (1) and south (1) of Italy, as well as to the
COGNETTI G.   +4 more
openaire   +3 more sources

GDC-0449 in patients with advanced chondrosarcomas: A French Sarcoma Group (FSG)/French and U.S. National Cancer Institutes phase II collaborative study.

Journal of Clinical Oncology, 2012
10005 Background: Chondrosarcomas (CS) exhibit a strong activation of hedgehog (Hh) signaling which plays a crucial role in cartilage tumorigenesis. Preclinical data show that hedgehog blockade reduces strongly chondrosarcoma cell proliferation and tumour size. GDC-0449 is a small-molecule antagonist of the Hh pathway. Methods: This is a multicentric
Antoine Italiano   +10 more
openaire   +1 more source

The impact of the U.S. Preventive Services Task Force guidelines on cancer screening

Journal of General Internal Medicine, 1990
The U.S. Preventive Services Task Force evaluated the medical literature, utilizing strict criteria to judge the merits of experimental trials designed to show benefit in screening for cancer. For individuals at normal risk, the task force was not able to make recommendations for or against screening for colorectal, prostate, skin, oral, or testicular ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy